International Journal of Drug Policy

Article	Citations
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis	326
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets	101
Tackling the overdose crisis: The role of safe supply	93
An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples	92
“Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanyl	76
Fentanyl shock: The changing geography of overdose in the United States	74
Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study	71
Safer opioid distribution in response to the COVID-19 pandemic	68
Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada	67
Kratom policy: The challenge of balancing therapeutic potential with public safety	67
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	65
COVID-19 and the health of people who use drugs: What is and what could be?	61
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	60
Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites	59
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	56
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	53
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis	52
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern	51
Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs	51
Ambiguous identities of drugs and people: A scoping review of opioid-related stigma	49
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	48
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	48
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	48
“We don’t got that kind of time, man. We’re trying to get high!”: Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs	47
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	47

Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston	47
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	45
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review	44
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	44
COVID-19 - Enacting a ‘new normal’ for people who use drugs	44
“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine use in a time of treatment expansion	43
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning	43
“Someone who is in this thing that I am suffering from”: The role of peers and other facilitators for task sharing substance use treatment in South African HIV care	42
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	41
‘It's too much, I'm getting really tired of it’: Overdose response and structural vulnerabilities among harm reduction workers in community settings	41
The value of unsolicited online data in drug policy research	41
Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.	41
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	41
Comparing Canadian and United States opioid agonist therapy policies	41
Access to cannabidiol without a prescription: A cross-country comparison and analysis	40
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	39
Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology	39
Narrative identity, rationality, and microdosing classic psychedelics	38
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	38
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	38
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	37
The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys	36
Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States	36
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all	36
Microdosing psychedelics: Motivations, subjective effects and harm reduction	36
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting	35
Evaluation of a drug checking service at a large scale electronic music festival in Portugal	35
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use	35
Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA	35
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	34
Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis	34
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	34
‘It's our safe sanctuary’: Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario	34
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	34
Known fentanyl use among clients of harm reduction sites in British Columbia, Canada	34
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	34
Adverse drug-related effects among electronic dance music party attendees	33
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	33
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	33
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures	32
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs	32
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	32
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study	32
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	32
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	31
Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs	31
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	31
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States	30
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia	30
Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone	30

Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England	30
Sellers’ risk perceptions in public and private social media drug markets	30
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	30
Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study	29
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain	29
Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals	28
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	28
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	28
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada	28
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants	27
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	27
“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site	27
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	26
Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States	26
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	26
Delineation of chemsex patterns of men who have sex with men in association with their sexual networks and linkage to HIV prevention	26
“It's like super structural” – Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia	26
Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?	25
The perfect storm: COVID-19, mass incarceration and the opioid epidemic	25
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	25
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis	25
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey	25
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review	25
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units	25
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand	25
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic	25
Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia	25
Housing in crisis: A qualitative study of the socio-legal contexts of residential evictions in Vancouver’s Downtown Eastside	25
Rural risk environments for hepatitis c among young adults in appalachian kentucky	25
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective	24
Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada	24
The impact of cannabis legalization in Uruguay on adolescent cannabis use	24
No “back to normal” after COVID-19 for our failed drug policies	24
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic	24
Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion	24
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study	24
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs	24
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama	24
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada	24
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey	24
Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland	23
Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state	23
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France	23
Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program	23
Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products	23
A qualitative study of e-cigarette emergence and the potential for renormalisation of smoking in UK youth	23
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies	23
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada	23
Price and product variation in Washington's recreational cannabis market	22
Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia	22
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use	22
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors	22
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives	22
When does the cutting of cocaine and heroin occur? The first large-scale study based on the chemical analysis of cocaine and heroin seizures in Switzerland	22
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)	22
MDMA-related deaths in Australia 2000 to 2018	22
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky	22
Re-configured pleasures: How young people feel good through abstaining or moderating their drinking	22
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia	22
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom	22
The protective effect of trusted dealers against opioid overdose in the U.S.	22
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting	21
Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011–2018	21
Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis	21
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland	21
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work	21
Drugs and drug wars as populist tropes in Asia: Illustrative examples and implications for drug policy	21
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking	21
Adulterants and altruism: A qualitative investigation of “drug checkers” in North America	21
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C	21
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers	21
Preliminary findings of the impact of COVID-19 on drugs crypto markets	21
Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa	20
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia	20
How high: Differences in the developments of cannabis markets in two legalized states	20
Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data	20
The Dark Web and cannabis use in the United States: Evidence from a big data research design	20
Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data	20
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs	20
The internet market for Kratom, an opioid alternative and variably legal recreational drug	20

Good Samaritan laws and overdose mortality in the United States in the fentanyl era	20
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets	20
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects	20
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth	20
Trajectories of retention in opioid agonist therapy in a Canadian setting	20
The impact of rurality on opioid-related harms: A systematic review of qualitative research	20
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants	20
The impacts of potency, warning messages, and price on preferences for Cannabis flower products	20
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project	19
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids	19
Producing the vulnerable subject in English drug policy	19
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions	19
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media	19
The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs	19
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department	19
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?	19
Pleasure and HIV biomedical discourse: The structuring of sexual and drug-related risks for gay and bisexual men who Party-n-Play	19
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington	19
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy	19
Digital chemsex support and care: The potential of just-in-time adaptive interventions	18
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast	18
Individual and network factors associated with HCV treatment uptake among people who inject drugs	18
Triangulating web & general population surveys: Do results match legal cannabis market sales?	18
Intensity of cannabis use: Findings from three online surveys	18
Alcohol policy has saved lives in the Russian Federation	18
Content analysis of online product descriptions from cannabis retailers in six US states	18
Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?	18
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples	18
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug	18
Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking	18
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	18
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study	17
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination	17
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling	17
Between gang talk and prohibition: The transfer of blame for County Lines	17
Digital figurations in the online trade of illicit drugs: A qualitative content analysis of darknet forums	17
The effectiveness of drug-related Good Samaritan laws: A review of the literature	17
“Another thing to live for”: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities	17
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.	17
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	17
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers	17
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research	17
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services	17
Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment	17
Government monopoly as an instrument for public health and welfare: Lessons for cannabis from experience with alcohol monopolies	17
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada	17
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence	16
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima	16
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts	16
Legal cannabis market shares during Canada's first year of recreational legalisation	16
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment	16
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia	16
Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada	16
Peer-delivered services for substance use in low- and middle-income countries: A systematic review	16
Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs	16
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options	16
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19	15
A systematic review of cigarette smoking trajectories in adolescents	15
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust	15
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination	15
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review	15
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	15
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	15
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs	15
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada	15
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons	15
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market	15
Connections built and broken: The ontologies of relapse	15
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions	15
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)	15
Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions	15
Alcohol policy in Iran: Policy content analysis	15
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations	15
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada	15
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	15
Critical studies of harm reduction: Overdose response in uncertain political times	15
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures	15
Testing the boundaries: Self-medicated testosterone replacement and why it is practised	14
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care	14
Leveraging crowdsourcing methods to collect qualitative data in addiction science: Narratives of non-medical prescription opioid, heroin, and fentanyl use	14
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex	14
Unity in diversity: A systematic review on the GHB using population	14
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles	14
Sources of cannabis among young adults and associations with cannabis-related outcomes	14
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting	14
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK	14
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services	14
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown	14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons	14
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction	14
Public support for alcohol control initiatives across seven countries	14
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity	14
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic	14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy	14
The effect of cannabis laws on opioid use	14
Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum	14
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	14
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis	14
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina	14
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study	14
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria	14
Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?	13
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders	13
Structural competency in the post-prison period for people who inject drugs: A qualitative case study	13
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran	13
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	13
Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties	13
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort	13
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care	13
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months	13
Frequently asked questions about dabbing concentrates in online cannabis community discussion forums	13
Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada	13
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply	13
Alcohol and drinking within the lives of midlife women: A meta-study systematic review	13
Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis	13
Designing drunkenness: How pubs, bars and nightclubs increase alcohol sales	13
Identifying opportunities for engaging the ‘community’ in local alcohol decision-making: A literature review and synthesis	13
Carfentanil on the darknet: Potential scam or alarming public health threat?	13
Uruguayan Cannabis Social Clubs: From activism to dispensaries?	13
Growing pains: An overview of cannabis quality control and quality assurance in Canada	13
A qualitative study of a publicly funded pharmacy-dispensed naloxone program	13
What explains the decline in adolescent binge-drinking in New Zealand?	12
Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets	12
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	12
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?	12
How medical are states’ medical cannabis policies?: Proposing a standardized scale	12
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	12
The use of multi-national web surveys for comparative analysis: Lessons from the European Web Survey on Drugs	12
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people	12
Understanding the reasons for using methamphetamine by sexual minority people in Dhaka, Bangladesh	12
Rethinking enhancement substance use: A critical discourse studies approach	12
Investigating opioid preference to inform safe supply services: A cross sectional study	12
A normalised future of addiction	12
Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors	12
Urban, individuals of color are impacted by fentanyl-contaminated heroin	12
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada	12
Beyond the narco frontier; rethinking an imaginary of the margins	12
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	12
The effect of injecting alone on the use of drug checking services among people who inject drugs	12
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan	12
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia	12
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities	12
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks	12
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar	12
How to think with models and targets: Hepatitis C elimination as a numbering performance	12

#studydrugs–Persuasive posting on Instagram	12
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage	12
Evidence that social-economic factors play an important role in drug overdose deaths	12
The prevalence and factors associated with smoking among lesbian and bisexual women: Analysis of the Australian National Drug Strategy Household Survey	12
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy	12
Challenges and opportunities for greater tobacco control in Japan	12
Critical realism and the ‘ontological politics of drug policy’	12
Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice	12
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics	12
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada	12
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia	12
Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran	11
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland	11
The Philippines’ antidrug campaign: Spatial and temporal patterns of killings linked to drugs	11
Overview of “home” cultivation policies and the case for community-based cannabis supply	11
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD	11
Hospital policy as a harm reduction intervention for people who use drugs	11
A policy mapping analysis of goals, target populations, and punitive notions in the U.S. congressional response to the opioid epidemic	11
Pharmacosex: Reimagining sex, drugs and enhancement	11
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis	11
Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity	11
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation	11
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C	11
Visitors of the Dutch drug checking services: Profile and drug use experience	11
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing	11
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study	11
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada	11
Medicinal cannabis and driving: the intersection of health and road safety policy	11
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts	11
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin	11
Trajectories of alcohol use problems based on early adolescent alcohol use: Findings from a 35 year population cohort	11
Uncertainty and risk: A framework for understanding pricing in online drug markets	11
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions	11
E-cigarette use is associated with susceptibility to tobacco use among Australian young adults	11
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	11
Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S.	11
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting	11
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada	11
Self-reported driving after marijuana use in association with medical and recreational marijuana policies	11
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic	11
Problematic alcohol use among fathers in Kenya: Poverty, people, and practices as barriers and facilitators to help acceptance	11
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy	11
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand	11
Co-creating a social science research agenda for clean sport: An international Delphi study	11
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	11
Seeking legitimacy for broad understandings of substance use	11
Risk and enabling environments in sport: Systematic doping as harm reduction	11
Analytical findings in used syringes from a syringe exchange program	11
Prevalence and correlates of amphetamine-type stimulant use among transgender women in Cambodia	10
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence	10
Towards an ontological politics of drug policy: Intervening through policy, evidence and method	10
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic	10
US drug overdose mortality: 2009–2018 increases affect young people who use drugs	10
Poppers, queer sex and a Canadian crackdown: Examining the experiences of alkyl nitrite use among young sexual minority men	10
Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis	10
Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States	10
Critical policy frontiers: The drugs-development-peacebuilding trilemma	10
The success rate of online illicit drug transactions during a global pandemic	10
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia	10
Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs	10
Compulsory and voluntary drug treatment models in China: A need for improved evidence-based policy and practice to reduce the loaded burden of substance use disorders	10
Service providers’ perceptions of barriers to the implementation of trauma-focused substance use services for women in Cape Town, South Africa	10
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment	10
Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex	10
Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose	10
‘I could have went down a different path’: Talking to people who used drugs problematically and service providers about Irish drug policy alternatives	10
“You need to just provide health services:” navigating the politics of harm reduction in the twin housing and overdose crises in Vancouver, BC	10
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions	10
Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002–2016	10
Latent patterns of polysubstance use among people who use opioids: A systematic review	10
An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries	10
“Is it banned? Is it illegal?”: Navigating Western Australia's regulatory environment for e-cigarettes	10
Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada	10
Evidence-making hepatitis C cure: Towards a science that knows more carefully	10
Naloxone distribution, trauma, and supporting community-based overdose responders	10
‘Vaping and fidget-spinners’: A qualitative, longitudinal study of e-cigarettes in adolescence	10
How the U.S.-Mexico border influences adolescent substance use: Youth participatory action research using photovoice	10
The impact of deportation policies on the substance using behaviors of US-citizen Latinos	10
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs	10
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway	10
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada	10
Suitability of infrared spectroscopy for drug checking in harm reduction centres	9
COVID-19 risks among people who inject drugs in Puerto Rico	9
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	9
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020	9
Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”	9
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study	9
Police officers’ knowledge, understanding and implementation of the Good Samaritan Drug Overdose Act in BC, Canada	9
Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey	9
Syringe access and health harms: Characterizing “landscapes of antagonism” in California's Central Valley	9
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing	9
Sisters are never alike? Drug control intensity in the Nordic countries	9
Progress of smoke-free policy adoption at district level in Indonesia: A policy diffusion study	9
Service provision and barriers to care for men who have sex with men engaging in chemsex and sexualised drug use in England	9
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis	9
From prohibition to regulation: A comparative analysis of the emergence and related outcomes of new legal cannabis policy models (Colorado, Washington State and Uruguay)	9
The emerging norms of e-cigarette use among adolescents: A meta-ethnography of qualitative evidence	9
‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada	9
Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada	9
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms	9
Complex cases – Complex representations of problems	9
Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey	9
Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum	9
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions	9
‘Synthetic cannabis’: A dangerous misnomer	9
High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs	9
Making legitimacy: Drug user representation in United Nations drug policy settings	9
Drinking to excess and the tipping point: An international study of alcohol intoxication in 61,000 people	9
Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose	9
A national case fatality study of drugs taken in intentional overdose	9
Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK	9
A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania	9
Reliable drug war data: The Consolidated Counterdrug Database and cocaine interdiction in the “Transit Zone”	9
Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward	9
What is a rural opioid risk and policy environment?	9
A review of the evidence on cigarettes with reduced addictiveness potential	9
Pathways to ‘recovery’ and social reintegration: The experiences of long-term clients of methadone maintenance treatment in an Irish drug treatment setting	8
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	8
‘Potential issues of morbidity, toxicity and dependence’: Problematizing the up-scheduling of over-the-counter codeine in Australia	8
Lessons learned recruiting a diverse sample of rural study participants during the COVID-19 pandemic	8
Problematisations in drug use policy, practice and research	8
Effects of messaging on public support for drug consumption rooms in scotland, UK	8
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	8
Steps toward a theory of place effects on drug use: Risk, marginality, and opportunity in small and remote California towns	8
Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study	8
Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco	8
Youth drinking in decline: What are the implications for public health, public policy and public debate?	8
Drivers of opioid use in Appalachian Pennsylvania: Cross-cutting social and community-level factors	8
A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison	8
Being ‘in place’, being ‘out of place’: Problematising marginalised drug users in two cities	8
‘We're in this together’: A content analysis of marketing by alcohol brands on Facebook and Instagram during the first UK Lockdown, 2020	8
The movement and translation of drug policy ideas: The case of ‘new recovery’	8
The harms of punishing substance use during pregnancy	8
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada	8
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot	8
The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders	8
Young people's use of e-cigarettes in Wales, England and Scotland before and after introduction of EU Tobacco Products Directive regulations: a mixed-method natural experimental evaluation	8
Drinking comfortably? Gender and affect among Danish pre-partiers	8
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs	8
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island	8
Ontological journeys: The lifeworld of opium across the Afghan-Iranian border in/out of the pharmacy	8
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.	8
“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison	8
Trajectories of initiation for the heroin-based drug whoonga – qualitative evidence from South Africa	8
Making sense of ‘‘drink responsibly’’ messages: Explorations of the understanding and interpretations of young Nigerians who use alcohol	8
Examining reactions to smoking and COVID-19 risk messages: An experimental study with people who smoke	8
Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach	8
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England	8
Conceptualizing overdose trauma: The relationships between experiencing and witnessing overdoses with PTSD symptoms among street-recruited female sex workers in Baltimore, Maryland	8
Diversity in addiction publishing	8
“One guy goes to jail, two people are ready to take his spot”: Perspectives on drug-induced homicide laws among incarcerated individuals	8
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island	8
Preventing transitions into injection drug use: A call for gender-responsive upstream prevention	8
Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey	8
The impact of legislation on acute synthetic cannabinoid harms resulting in ambulance attendance	8
An evidence synthesis of strategies, enablers and barriers for keeping secrets online regarding the procurement and supply of illicit drugs	8
Deconstructing prohibitionist ideology: A sociocognitive approach to understand opinions on UK drug policy and the law	8
Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program	7
Pharmacies and features of the built environment associated with opioid overdose: A geospatial comparison of rural and urban regions in Alabama, USA	7
A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin use	7
Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal	7
Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study	7
Narratives of people who inject drugs on factors contributing to opioid overdose	7
Network measures of advice-seeking and resource sharing are related to well-being in recovery homes	7
Care, agency and criminality: Making sense of authorised extended distribution in the accounts of key stakeholders	7
New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary	7
Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center	7
Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky	7
Does the gateway theory justify a ban on nicotine vaping in Australia?	7
Effects of changes to the taxation of beer on alcohol consumption and government revenue in Australia	7
2,4 dinitrophenol: It's not just for men	7
Enhancement motivations for using prescription drugs among young adults in Nigeria	7
The ever-changing narrative: Supervised injection site policy making in Ontario, Canada	7
“It's a revolving door”: Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success	7
Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain	7
The Pat Jasan drug eradication social movement in northern Myanmar, part two: Deep culture & cultural psychology	7
HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study	7
Assembling and diversifying social contexts of recovery	7
Issues in the establishment of a therapeutic cannabis market under Jamaica's Dangerous Drugs Amendment Act 2015	7
“With a PICC line, you never miss”: The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs	7
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination	7
Supplying synthetic opioids during a pandemic: An early look at North America	7
Cocalero women and peace policies in Colombia	7
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model	7
Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs	7
Cannabis use and mental health among young sexual and gender minority men: A qualitative study	7
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore	7
Estimating the size of crack cocaine users in France: Methods for an elusive population with high heterogeneity	7
COVID-19 and people who use drugs; seizing opportunity in times of chaos	7
Psychedelic-assisted therapies: The past, and the need to move forward responsibly	7
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation	7
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting	7
‘Whatever we have, we owe it to coca’. Insights on armed conflict and the coca economy from Argelia, Colombia	7
Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis	7
“How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?”	7
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants	7
Methadone maintenance treatment is swapping one drug for another, and that's why it works: Towards a treatment-based critique of the war on drugs	7
Twitter discourse on nicotine as potential prophylactic or therapeutic for COVID-19	7
Factors associated with state legislators’ support for opioid use disorder parity laws	7
‘The opportunity to have their say’? Identifying mechanisms of community engagement in local alcohol decision-making	7